ID22650A - Penggunaan penghambat-penghambat lipase usus lambung - Google Patents

Penggunaan penghambat-penghambat lipase usus lambung

Info

Publication number
ID22650A
ID22650A IDW990792A ID990792A ID22650A ID 22650 A ID22650 A ID 22650A ID W990792 A IDW990792 A ID W990792A ID 990792 A ID990792 A ID 990792A ID 22650 A ID22650 A ID 22650A
Authority
ID
Indonesia
Prior art keywords
lipase
lights
inhibitors
lipase lights
lights inhibitors
Prior art date
Application number
IDW990792A
Other languages
English (en)
Indonesian (id)
Inventor
Jonathan Brian Hauptman
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID22650(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ID22650A publication Critical patent/ID22650A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
IDW990792A 1997-02-05 1998-01-29 Penggunaan penghambat-penghambat lipase usus lambung ID22650A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05

Publications (1)

Publication Number Publication Date
ID22650A true ID22650A (id) 1999-12-02

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990792A ID22650A (id) 1997-02-05 1998-01-29 Penggunaan penghambat-penghambat lipase usus lambung

Country Status (27)

Country Link
US (1) US6147108A (cs)
EP (1) EP1017408B1 (cs)
JP (1) JP2001509173A (cs)
KR (1) KR100479968B1 (cs)
CN (1) CN1154505C (cs)
AR (1) AR011106A1 (cs)
AT (1) ATE292975T1 (cs)
AU (1) AU740375B2 (cs)
BR (1) BR9807655A (cs)
CA (1) CA2278854C (cs)
CZ (1) CZ295567B6 (cs)
DE (1) DE69829763T2 (cs)
DK (1) DK1017408T3 (cs)
ES (1) ES2239799T3 (cs)
HU (1) HU230834B1 (cs)
ID (1) ID22650A (cs)
IL (1) IL131007A0 (cs)
ME (1) ME00578A (cs)
NO (1) NO324452B1 (cs)
NZ (1) NZ336755A (cs)
PL (1) PL191222B1 (cs)
PT (1) PT1017408E (cs)
RU (1) RU2201272C2 (cs)
TR (1) TR199901853T2 (cs)
WO (1) WO1998034630A1 (cs)
YU (1) YU34199A (cs)
ZA (1) ZA98753B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU740375B2 (en) * 1997-02-05 2001-11-01 F. Hoffmann-La Roche Ag Use of gastrointestinal lipase inhibitors
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
DE60138333D1 (de) 2000-03-14 2009-05-28 Unilever Nv Variabele Domänen der schweren Kette eines Antikörpers gegen menschliche Ernährungslipasen und deren Verwendungen
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7060675B2 (en) 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
WO2003105768A2 (en) 2002-06-13 2003-12-24 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
RU2248793C1 (ru) * 2003-11-13 2005-03-27 Лазебник Леонид Борисович Способ лечения стеатогепатитов
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
PL2626368T3 (pl) 2004-07-19 2017-06-30 Biocon Limited Koniugaty insulina-oligomer, ich formulacje i zastosowania
US8036727B2 (en) * 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
WO2006110859A2 (en) 2005-04-13 2006-10-19 Glucolight Corporation Method for data reduction and calibration of an oct-based blood glucose monitor
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
DE602007008567D1 (de) * 2007-09-12 2010-09-30 Mader S R L Pharmazeutische Zusammensetzungen zur oralen Verabreichung bei der Behandlung von Adipositas-Patienten
MX2010004072A (es) * 2007-10-15 2010-09-14 Inventis Dds Pvt Ltd Composicion farmaceutica de orlistat.
ES2664822T3 (es) 2007-10-16 2018-04-23 Biocon Limited Una composición farmacéutica sólida administrable por vía oral y un proceso de la misma
US8571617B2 (en) 2008-03-04 2013-10-29 Glt Acquisition Corp. Flowometry in optical coherence tomography for analyte level estimation
WO2010042499A1 (en) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
WO2017161043A1 (en) * 2016-03-16 2017-09-21 The J. David Gladstone Institutes Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents
WO2019018849A1 (en) * 2017-07-21 2019-01-24 Kieu Hoang STATINES (ATORVASTATIN) THAT CAN REDUCE GLYCEMIA LEVEL IN DIABETICS

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
AU740375B2 (en) * 1997-02-05 2001-11-01 F. Hoffmann-La Roche Ag Use of gastrointestinal lipase inhibitors
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions

Also Published As

Publication number Publication date
JP2001509173A (ja) 2001-07-10
KR20000070733A (ko) 2000-11-25
CA2278854C (en) 2014-03-04
HUP0001014A2 (hu) 2000-08-28
PT1017408E (pt) 2005-07-29
DE69829763D1 (de) 2005-05-19
CA2278854A1 (en) 1998-08-13
DK1017408T3 (da) 2005-08-01
AU740375B2 (en) 2001-11-01
CZ265199A3 (cs) 2000-02-16
ZA98753B (en) 1998-08-05
IL131007A0 (en) 2001-01-28
NO993717D0 (no) 1999-07-30
RU2201272C2 (ru) 2003-03-27
HK1025251A1 (en) 2000-11-10
YU34199A (sh) 2002-08-12
PL191222B1 (pl) 2006-03-31
ATE292975T1 (de) 2005-04-15
HU230834B1 (hu) 2018-07-30
ME00578A (en) 2011-12-20
CN1246798A (zh) 2000-03-08
EP1017408A1 (en) 2000-07-12
DE69829763T2 (de) 2006-04-13
PL334975A1 (en) 2000-03-27
AR011106A1 (es) 2000-08-02
TR199901853T2 (xx) 1999-12-21
CZ295567B6 (cs) 2005-08-17
NZ336755A (en) 2001-06-29
AU6616998A (en) 1998-08-26
BR9807655A (pt) 2000-02-15
CN1154505C (zh) 2004-06-23
WO1998034630A1 (en) 1998-08-13
KR100479968B1 (ko) 2005-03-30
HUP0001014A3 (en) 2000-12-28
NO993717L (no) 1999-10-04
US6147108A (en) 2000-11-14
NO324452B1 (no) 2007-10-22
EP1017408B1 (en) 2005-04-13
ES2239799T3 (es) 2005-10-01

Similar Documents

Publication Publication Date Title
ID22650A (id) Penggunaan penghambat-penghambat lipase usus lambung
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
FI951553L (fi) 1H-indoli-glyoksyyliamidi-sPLA2-inhibiittoreita
FI965019A7 (fi) Entsyymi-inhibiittoreita
PT927183E (pt) Inibidores espirociclicos de metaloproteases
NO995802L (no) Anvendelse av oljelegemer
ID24612A (id) Hidrogenolisis gliserol
ID19198A (id) Inhibitor metaloprotease heterosiklik
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
ID18416A (id) Inhibitor metaloprotease diheterosiklik
PT979240E (pt) Inibidores de serina-protease
PT1047450E (pt) Combinacoes inibidor ace - inibidor mmp
ZA983065B (en) Inhibitors of protein farnesyltranferase
ID24270A (id) Penghilang sumbatan keratotik
ID23437A (id) Penghilang sumbatan keratotik
ID22379A (id) Hidrogenasi imina enamina
ID19540A (id) Metode pembuatan turunan-turunan benzofenon
DE69828361D1 (de) Apoptose-inhibitor
DE69720957T2 (de) Ace-hemmer
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID17328A (id) Pemurnian epsilon-kaprolaktam
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
UA1821S (uk) Комплект етикеток
UA2115S (uk) Комплект етикеток